Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
International Sweetene...International Sweetener Colloquium
Not Confirmed
Not Confirmed
22-25 February, 2026
Not Confirmed
Not Confirmed
23-25 February, 2026
Clinical Trial Supply ...Clinical Trial Supply Europe
Not Confirmed
Not Confirmed
24-25 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
International Sweetene...International Sweetener Colloquium
Industry Trade Show
Not Confirmed
22-25 February, 2026
Industry Trade Show
Not Confirmed
23-25 February, 2026
Clinical Trial Supply ...Clinical Trial Supply Europe
Industry Trade Show
Not Confirmed
24-25 February, 2026
Digital content

18 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260218034666/en/Merck-and-Mayo-Clinic-Announce-New-Research-and-Development-Collaboration-to-Support-AI-Enabled-Drug-Discovery-and-Precision-Medicine

12 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/12/3237722/0/en/Profusa-and-Mayo-Clinic-collaborate-to-Advance-High-Impact-Clinical-Applications-of-Oxygen-Monitoring-Technologies.html

02 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260202593149/en/Largest-Published-Study-of-Molecular-Residual-Disease-MRD-in-Stage-III-Colon-Cancer-Shows-Guardant-Reveal-Blood-Test-More-Precisely-Identifies-Risk-of-Recurrence-After-Surgery-to-Support-Timely-Treatment-Decisions

20 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/20/3221710/0/en/BrightInsight-Announces-Multi-Million-Dollar-Strategic-Investment-to-Advance-its-AI-Enabled-Medication-Persistence-and-Adherence-Solutions.html

13 Jan 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-01-13/biocartis-to-collaborate-with-mayo-clinic-on-breast-cancer-gene-signatures

12 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/12/3217084/0/en/Press-Release-Biocartis-NV-Biocartis-to-collaborate-with-Mayo-Clinic-on-breast-cancer-gene-signatures.html
ABOUT THIS PAGE
Mayo Clinic is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of Ribavirin bulk offered by Mayo Clinic
Find a price of COMMITTEE ON SAFETY OF THERAPEUTIC AGENTS bulk offered by Mayo Clinic
Find a price of HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (IMMUNEX), AEROSOL bulk offered by Mayo Clinic